DE60102357D1 - Verfahren zur herstellung von quetiapin und intermediate dafür - Google Patents
Verfahren zur herstellung von quetiapin und intermediate dafürInfo
- Publication number
- DE60102357D1 DE60102357D1 DE60102357T DE60102357T DE60102357D1 DE 60102357 D1 DE60102357 D1 DE 60102357D1 DE 60102357 T DE60102357 T DE 60102357T DE 60102357 T DE60102357 T DE 60102357T DE 60102357 D1 DE60102357 D1 DE 60102357D1
- Authority
- DE
- Germany
- Prior art keywords
- quetiapine
- intermediates therefor
- producing
- formula
- producing quetiapine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- URKOMYMAXPYINW-UHFFFAOYSA-N quetiapine Chemical compound C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 URKOMYMAXPYINW-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004431 quetiapine Drugs 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 3
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D281/16—[b, f]-condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0000283A HU227039B1 (en) | 2000-01-25 | 2000-01-25 | New process for the production of quetiapine and intermediates therefor |
HU0000283 | 2000-01-25 | ||
PCT/HU2001/000010 WO2001055125A1 (en) | 2000-01-25 | 2001-01-24 | A process for the preparation of quetiapine and intermediates therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60102357D1 true DE60102357D1 (de) | 2004-04-22 |
DE60102357T2 DE60102357T2 (de) | 2005-01-13 |
Family
ID=89978038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2001602357 Expired - Lifetime DE60102357T2 (de) | 2000-01-25 | 2001-01-24 | Verfahren zur herstellung von quetiapin und intermediate dafür |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1252151B1 (de) |
CN (2) | CN1239487C (de) |
AT (1) | ATE261949T1 (de) |
AU (1) | AU3214601A (de) |
CZ (1) | CZ301236B6 (de) |
DE (1) | DE60102357T2 (de) |
DK (1) | DK1252151T3 (de) |
ES (1) | ES2217115T3 (de) |
HR (1) | HRP20020579B1 (de) |
HU (1) | HU227039B1 (de) |
PL (1) | PL211338B1 (de) |
RU (1) | RU2258067C2 (de) |
SI (1) | SI1252151T1 (de) |
SK (1) | SK287171B6 (de) |
UA (1) | UA73547C2 (de) |
WO (1) | WO2001055125A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0200503A3 (en) | 1999-03-15 | 2005-06-28 | Axys Pharmaceuticals Inc South | N-cyanomethyl amides as protease inhibitors and pharmaceutical compositions containing them |
US7030116B2 (en) | 2000-12-22 | 2006-04-18 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
JP2004523506A (ja) | 2000-12-22 | 2004-08-05 | アクシス・ファーマシューティカルズ・インコーポレイテッド | カテプシン阻害剤としての新規な化合物と組成物 |
PL369312A1 (en) | 2001-09-14 | 2005-04-18 | Aventis Pharmaceuticals Inc. | Novel compounds and compositions as cathepsin inhibitors |
CN1324018C (zh) | 2001-11-14 | 2007-07-04 | 安万特药物公司 | 作为组织蛋白酶s抑制剂的寡肽以及含有它们的组合物 |
WO2004076431A1 (en) * | 2003-02-22 | 2004-09-10 | Teva Pharmaceutical Industries Ltd. | Synthesis of quetiapine and pharmaceutically acceptable salts thereof |
MXPA05011406A (es) | 2003-04-23 | 2005-12-12 | Medarex Inc | Anticuerpos humanizados para el receptor-1 de interferon alfa (ifnar-1). |
PL195728B1 (pl) * | 2003-07-18 | 2007-10-31 | Helm Ag | Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny |
ES2223294B2 (es) * | 2003-08-08 | 2005-10-01 | Vita Cientifica, S.L. | Procedimiento de preparacion de un compuesto farmaceuticamente activo. |
JP2007505864A (ja) * | 2003-09-23 | 2007-03-15 | フェルミオン オサケ ユキチュア | クエチアピンの製造 |
CA2538866A1 (en) * | 2003-09-23 | 2005-03-31 | Fermion Oy | Preparation of quetiapine |
KR101038389B1 (ko) * | 2004-06-23 | 2011-06-01 | 에스케이바이오팜 주식회사 | 11-(4-[2-(2-히드록시에톡시)에틸]-1-피페라지닐)-디벤조[b,f][1,4]티아제핀의 제조방법 |
WO2006035293A1 (en) * | 2004-09-27 | 2006-04-06 | Ranbaxy Laboratories Limited | Polymorphic forms of quetiapine hemifumarate |
GB0425729D0 (en) * | 2004-11-23 | 2004-12-22 | Pliva Res & Dev Ltd | Heterocyclic compounds |
WO2006056772A2 (en) * | 2004-11-23 | 2006-06-01 | Pliva Hrvatska D.O.O. | Salts of quetiapine |
ES2234447B1 (es) * | 2005-03-07 | 2006-03-01 | Union Quimico-Farmaceutica S.A. | Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina. |
US7687622B2 (en) | 2005-04-14 | 2010-03-30 | Teva Pharmaceutical Industries, Ltd | Process for preparing quetiapine fumarate |
WO2007036599A1 (en) | 2005-09-30 | 2007-04-05 | Fermion Oy | New crystallization process of quetiapine hemifumarate |
DK2262486T3 (da) | 2008-08-01 | 2013-03-25 | Krka Tovarna Zdravil D D Novo Mesto | Quetiapin sammensætning |
CN101676275B (zh) * | 2008-09-17 | 2014-05-07 | 北京德众万全药物技术开发有限公司 | 一种富马酸喹硫平的制备方法 |
WO2010100623A1 (en) | 2009-03-04 | 2010-09-10 | Ranbaxy Laboratories Limited | Process for the preparation of quetiapine fumarate |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH422793A (de) * | 1961-07-20 | 1966-10-31 | Wander Ag Dr A | Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine |
CH476743A (de) * | 1962-06-08 | 1969-08-15 | Wander Ag Dr A | Verfahren zur Herstellung von Amidinen der Dibenzo (b,e) (1,4)-diazepin-Reihe |
US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
US3560622A (en) * | 1967-10-13 | 1971-02-02 | American Cyanamid Co | Trifluoromethyl oxazepines,thiazepines and diazepines as anti-inflammatory agents |
-
2000
- 2000-01-25 HU HU0000283A patent/HU227039B1/hu not_active IP Right Cessation
-
2001
- 2001-01-24 CN CNB2004100027829A patent/CN1239487C/zh not_active Expired - Fee Related
- 2001-01-24 AU AU32146/01A patent/AU3214601A/en not_active Abandoned
- 2001-01-24 UA UA2002086977A patent/UA73547C2/uk unknown
- 2001-01-24 DE DE2001602357 patent/DE60102357T2/de not_active Expired - Lifetime
- 2001-01-24 CN CNB018040993A patent/CN1177839C/zh not_active Expired - Fee Related
- 2001-01-24 CZ CZ20022463A patent/CZ301236B6/cs not_active IP Right Cessation
- 2001-01-24 WO PCT/HU2001/000010 patent/WO2001055125A1/en active IP Right Grant
- 2001-01-24 DK DK01904235T patent/DK1252151T3/da active
- 2001-01-24 PL PL355726A patent/PL211338B1/pl unknown
- 2001-01-24 SI SI200130107T patent/SI1252151T1/xx unknown
- 2001-01-24 AT AT01904235T patent/ATE261949T1/de active
- 2001-01-24 ES ES01904235T patent/ES2217115T3/es not_active Expired - Lifetime
- 2001-01-24 EP EP01904235A patent/EP1252151B1/de not_active Expired - Lifetime
- 2001-01-24 RU RU2002122723/04A patent/RU2258067C2/ru not_active IP Right Cessation
- 2001-01-24 SK SK1060-2002A patent/SK287171B6/sk not_active IP Right Cessation
-
2002
- 2002-07-05 HR HR20020579A patent/HRP20020579B1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CZ301236B6 (cs) | 2009-12-16 |
SK10602002A3 (sk) | 2002-11-06 |
EP1252151B1 (de) | 2004-03-17 |
AU3214601A (en) | 2001-08-07 |
RU2258067C2 (ru) | 2005-08-10 |
CZ20022463A3 (cs) | 2002-10-16 |
PL355726A1 (en) | 2004-05-17 |
DK1252151T3 (da) | 2004-07-12 |
HRP20020579A2 (en) | 2004-08-31 |
WO2001055125A1 (en) | 2001-08-02 |
HU0000283D0 (en) | 2000-03-28 |
DE60102357T2 (de) | 2005-01-13 |
CN1396916A (zh) | 2003-02-12 |
HU227039B1 (en) | 2010-05-28 |
ES2217115T3 (es) | 2004-11-01 |
SI1252151T1 (en) | 2004-08-31 |
EP1252151A1 (de) | 2002-10-30 |
SK287171B6 (sk) | 2010-02-08 |
RU2002122723A (ru) | 2004-01-10 |
HUP0000283A3 (en) | 2002-11-28 |
ATE261949T1 (de) | 2004-04-15 |
UA73547C2 (uk) | 2005-08-15 |
CN1177839C (zh) | 2004-12-01 |
HRP20020579B1 (en) | 2005-08-31 |
CN1239487C (zh) | 2006-02-01 |
CN1537847A (zh) | 2004-10-20 |
HUP0000283A2 (hu) | 2002-04-29 |
PL211338B1 (pl) | 2012-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60102357D1 (de) | Verfahren zur herstellung von quetiapin und intermediate dafür | |
BR0111472A (pt) | Processo para a preparação de um composto, composto, e, forma polimórfica de um composto | |
NO20075071L (no) | Fremgangsmate for fremstilling av et 11-(4-substituert-1-piperazinyl) dibenzo [b,f] [1,4]thiazepin dericvat2005 | |
DE69835322D1 (de) | Neue tetralon-oder benzopyranon-derivate und ein verfahren zu ihrer herstellung | |
ATE277915T1 (de) | Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen | |
ATE407127T1 (de) | Verfahren zur herstellung von beraprost und dessen salzen | |
ATE280167T1 (de) | Zwischenprodukte und ein verfahren zur herstellung von beta3-adrenergischer rezeptor- agoniste | |
ATE367383T1 (de) | Verfahren zur herstellung von 11-(4-(2-(2- hydroxyethoxy)ethyl)-1-piperazinyl)dibenzo(b,f) 1,4)thiazepin | |
ATE281434T1 (de) | Verfahren zur herstellung von benzoperhydroisoindolen | |
ATE371654T1 (de) | Verfahren zur herstellung von 11-(1- piperazinyl)dibenzo(b,f)(1,4)-thiazepin, ein zwischenprodukt in der synthese des antipsychotischen arzneimittels quetiapin | |
DE60116201D1 (de) | Verfahren zur Herstellung von Cephalosporin-Verbindungen und Zwischenprodukte für die Synthese dieser Verbindungen | |
ATE402136T1 (de) | Verfahren zur herstellung von aminoalkoxybenzylaminen und aminoalkoxybenzonitrilen als zwischenprodukte | |
ATE223414T1 (de) | Prozess zur herstellung von zwischebprodukten für imidazodeazepinen | |
ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
DE60003169D1 (de) | Verfahren zur herstellung von [s-(r*,s*)]-g(b)-[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl] amino]-3-pyridinpropansäurederivate | |
ATE234288T1 (de) | Verfahren zur herstellung eines buthylthuio- isochinolinderivates und zwischenprodukte dafür | |
DE60009945D1 (de) | Beta-d-thioxylos-derivate, verfahren zur herstellung und verwendung als arzneimittel | |
PL354677A1 (en) | A process for the preparation of {2-[4-(alpha-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy}acetic acid and novel intermediates therefor | |
ATE311375T1 (de) | Verfahren zur herstellung antiosteoporicagenz | |
HRP20020021B1 (en) | Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates | |
ATE404540T1 (de) | Verfahren zur herstellung von 1-substituierten 5- chlor-4methylpyrazolen | |
FR2854403A1 (fr) | Nouveau procede et intermediaires de preparation de composes 19-nor-steroides 17-halogenes | |
WO2004089890A3 (en) | Process and intermediates for preparing benzazepines | |
ATE297478T1 (de) | Verfahren zur herstellung von orthocarbonsäuretrialkylestern | |
ZA200200158B (en) | Process for producing dibenzothiazepine derivatives. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1252151 Country of ref document: EP Representative=s name: STOLMAR & PARTNER, DE |